Eltrog 50mg Tablet is used to treat,
- Low platelet counts are caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection.
- Severe aplastic anemia.
| MRP | : |
|
| Price | : | ₹1,000.00 |
| You Save | : | ₹406.25 (28.89%) |
7 Tablet(s) In A Strip
Eltrog 50mg Tablet is an anticoagulant medication that falls under the category of thrombopoietin (TPO) receptor agonists, featuring the active ingredient Eltrombopag. It is utilized to address low platelet counts resulting from primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. ITP is an autoimmune condition where the immune system attacks and destroys platelets. Platelets are essential blood cells that facilitate clotting and safeguard the walls of blood vessels. A deficiency in platelet levels can lead to significant bleeding and bruising. Additionally, this tablet is prescribed to adults for treating low blood counts associated with severe aplastic anaemia, a critical blood disorder characterized by the bone marrow’s inability to produce sufficient new blood cells.
This medication is contraindicated for individuals with known hypersensitivity or allergic reactions to Eltrog or its components. Allergic responses can vary from mild to severe, potentially manifesting as rash, itching, swelling, dizziness, or breathing difficulties. Eltrog 50mg Tablet is not suitable for patients suffering from severe liver impairment or active liver disease. The drug carries a risk of hepatotoxicity, as evidenced by elevated liver enzymes and bilirubin levels. Administering this medication to those with severe liver conditions may exacerbate liver function, hence caution is essential. Your physician will recommend monitoring for cataracts, and if you do not undergo regular eye examinations, they should arrange for consistent testing. Additionally, you may be evaluated for bleeding in or around your retina, which is the light-sensitive layer of cells located at the back of the eye.
Should you discontinue the use of this tablet, your blood platelet count is likely to decrease again within a few days. Your platelet levels will be closely monitored, and your doctor will advise on necessary precautions. An excessively high platelet count may elevate the risk of blood clot formation. However, blood clots can also develop with normal or even low platelet counts. Your physician will modify your dosage of this medication to ensure that your platelet count remains within a safe range. Avoid taking this tablet without consulting your healthcare provider.
Eltrog 50mg Tablet is used to treat,
Eltrog 50mg Tablet stimulates megakaryocytes (the large bone marrow cells) responsible for producing platelets. By raising the number of platelets in the blood, this drug prevents bleeding and bruising.
Notify your healthcare provider regarding all medications you are taking, which encompasses prescription drugs, over-the-counter medications, nutritional or vitamin supplements, and herbal products. Some medications, such as antacids, statins, ciclosporin, methotrexate, topotecan, lopinavir, or ritonavir, along with vitamin and mineral supplements, may interact with Eltrog 50mg Tablet, potentially diminishing its effectiveness and leading to unwanted side effects.
This is a prescription medication that can be taken orally.
Your physician will determine the appropriate dosage and length of treatment based on your medical condition and other considerations.
Always use the Eltrog 50mg Tablet as directed by your healthcare provider.
You may take the tablet with or without food.
Do not chew, crush, or split the tablet.
Swallow the entire tablet with water.
Common
Make sure that within 2 hours after or 4 hours before taking this medication, you avoid consuming dairy products (like cheese or butter), milk or milkshakes, antacids, and supplements that contain iron, aluminum, magnesium, calcium, selenium, zinc, or calcium. If you miss a dose of Eltrog 50mg Tablet, take your next dose at the regular time. Do not exceed one dose of this medication in a day. Do not discontinue this tablet without consulting your physician. If your doctor recommends stopping the treatment, your platelet levels will be monitored weekly for four weeks. If you have any questions about the use of this medication, consult your doctor.
Molecule Name: Eltrombopag
Therapeutic Class: Anticoagulant
Pharmacological Class: Thrombopoietin (TPO) receptor agonist
Indications:
1. Low platelet counts caused by immune primary thrombocytopenia (ITP) or hepatitis C virus (HCV) infection.
2. Severe aplastic anaemia.
At Medfast, we’re dedicated to bringing you accurate, trustworthy, and expert-vetted health information. Our primary goal is to ensure you receive content that you can rely on.
It’s crucial to understand that everything on this website is for general information purposes only. This content is not a substitute for professional medical advice, diagnosis, or treatment. We can’t stress enough the importance of consulting with your own doctor. They are the only ones who can provide tailored advice for your specific health concerns or medication questions.
Please, never ignore or delay seeking professional medical advice because of something you’ve read here. Our fundamental mission is to support and enhance the doctor-patient relationship, not to replace it.
We maintain strict quality controls on all our partner retailers, so that you always get standard quality products.
100% secure and trusted payment protection
We have a new and dynamic return window policy for medicines and healthcare items. Refer FAQs section for more details.